Foghorn Therapeutics (FHTX) Current Deferred Revenue (2020 - 2026)
Foghorn Therapeutics' Current Deferred Revenue was $36.59 million in Q2 2026, down 38.7% from $59.72 million a year earlier and down 30.0% from the prior quarter.
Powered by 
Analysis
Foghorn Therapeutics (FHTX) Current Deferred Revenue (2020 - 2026) Analysis & Trends
At the end of FY2025, Current Deferred Revenue at Foghorn Therapeutics came in at $43.19 million, down 5.3% from FY2024.
- Current Deferred Revenue shows a five-year compound annual growth rate of 84.4% (FY2020 to FY2025).
- In earlier years, Current Deferred Revenue was $45.61 million in FY2024 (+32.0%), $34.55 million in FY2023 (+5.3%), $32.82 million in FY2022 (+15.9%) and $28.32 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Current Deferred Revenue since Q3 2024.
- Compared with a year earlier, Current Deferred Revenue was higher in six of the last eight quarters, with growth averaging 32.2%.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q3 2025 (growth of 95.6%); the worst was Q2 2026 (a decline of 38.7%).
- Per Business Quant data, FHTX's Current Deferred Revenue in the three quarters before Q2 2026 was $52.3 million (Q1 2026), $43.19 million (Q4 2025) and $65.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Foghorn Therapeutics | 113.93 Mn | -202.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 18.87 Mn |
| Jun 30, 2026 | 36.59 Mn |
| Mar 31, 2026 | 52.30 Mn |
| Dec 31, 2025 | 43.19 Mn |
| Sep 30, 2025 | 65.30 Mn |
| Jun 30, 2025 | 59.72 Mn |
| Mar 31, 2025 | 51.67 Mn |
| Dec 31, 2024 | 45.61 Mn |
| Sep 30, 2024 | 33.38 Mn |
| Jun 30, 2024 | 31.23 Mn |
| Mar 31, 2024 | 31.50 Mn |
| Dec 31, 2023 | 34.55 Mn |
| Sep 30, 2023 | 28.35 Mn |
| Jun 30, 2023 | 33.90 Mn |
| Mar 31, 2023 | 33.33 Mn |
| Dec 31, 2022 | 32.82 Mn |
| Sep 30, 2022 | 33.16 Mn |
| Jun 30, 2022 | 30.57 Mn |
| Mar 31, 2022 | 30.06 Mn |
| Dec 31, 2021 | 28.32 Mn |
API Access
Foghorn Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=FHTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "FHTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=FHTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();